BHVN
T. Rowe Price Associates’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-356,257
| Closed | -$53.9M | – | 3063 |
|
|
2022
Q3 | $53.9M | Sell |
356,257
-165,323
| -32% | -$25M | 0.01% | 628 |
|
|
2022
Q2 | $76M | Buy |
521,580
+5,809
| +1% | +$846K | 0.01% | 742 |
|
|
2022
Q1 | $61.2M | Buy |
515,771
+49,794
| +11% | +$5.9M | 0.01% | 900 |
|
|
2021
Q4 | $64.2M | Buy |
465,977
+41,760
| +10% | +$5.75M | 0.01% | 909 |
|
|
2021
Q3 | $58.9M | Buy |
424,217
+53,488
| +14% | +$7.43M | 0.01% | 952 |
|
|
2021
Q2 | $36M | Buy |
370,729
+216,182
| +140% | +$21M | ﹤0.01% | 1144 |
|
|
2021
Q1 | $10.6M | Sell |
154,547
-169
| -0.1% | -$11.6K | ﹤0.01% | 1385 |
|
|
2020
Q4 | $13.3M | Buy |
154,716
+128,840
| +498% | +$11M | ﹤0.01% | 1307 |
|
|
2020
Q3 | $1.68M | Buy |
25,876
+366
| +1% | +$23.8K | ﹤0.01% | 1598 |
|
|
2020
Q2 | $1.87M | Sell |
25,510
-728
| -3% | -$53.2K | ﹤0.01% | 1551 |
|
|
2020
Q1 | $893K | Buy |
26,238
+462
| +2% | +$15.7K | ﹤0.01% | 1748 |
|
|
2019
Q4 | $1.4M | Buy |
25,776
+2,846
| +12% | +$155K | ﹤0.01% | 1740 |
|
|
2019
Q3 | $957K | Buy |
22,930
+4,099
| +22% | +$171K | ﹤0.01% | 1837 |
|
|
2019
Q2 | $825K | Buy |
+18,831
| New | +$825K | ﹤0.01% | 1911 |
|
|
2018
Q1 | – | Sell |
-375,048
| Closed | -$10.1M | – | 2622 |
|
|
2017
Q4 | $10.1M | Buy |
375,048
+1,100
| +0.3% | +$29.7K | ﹤0.01% | 1328 |
|
|
2017
Q3 | $14M | Sell |
373,948
-122,180
| -25% | -$4.57M | ﹤0.01% | 1266 |
|
|
2017
Q2 | $12.4M | Buy |
+496,128
| New | +$12.4M | ﹤0.01% | 1280 |
|